Original Founders of Akkermansia Muciniphila Bring First Gut Health Product to U.S. Consumer Market
27 juin 2024 11h11 HE
|
The Akkermansia Company
The Akkermansia Company, founded by the first scientists to discover and decode Akkermansia muciniphila, announces its launch into the U.S. consumer market
Floré Clinical Teams Up with Evexia Diagnostics to Distribute Personalized Microbiome Mapping Technology to 20,000 Clinicians
04 juin 2024 09h00 HE
|
Sun Genomics
SAN DIEGO and WASHINGTON, Conn., June 04, 2024 (GLOBE NEWSWIRE) -- Floré Clinical, a leader in gut health testing specializing in made-to-order probiotics based on an individual’s gut microflora,...
Alberta Cancer Foundation announces new Breakthrough Fund recipient, driving commercial success of cancer research breakthroughs
31 mai 2024 12h00 HE
|
Alberta Cancer Foundation
Alberta Cancer Foundation announces new Breakthrough Fund recipient, driving commercial success of cancer research breakthroughs
Local startup Oncobiotix
L'Alliance Promotion Microbiote devient l’European Microbiome Innovation for Health : une étape majeure pour structurer la filière d’excellence européenne du microbiote
14 mai 2024 05h53 HE
|
ALLIANCE PROMOTION MICROBIOTE
L'Alliance Promotion Microbiote devient l’European Microbiome Innovation for Health : une étape majeure pour structurer la filière d’excellence européenne du microbiote Paris - France – 14 mai...
The Alliance Promotion Microbiote is becoming the European Microbiome Innovation for Health: a major step towards structuring the European microbiome excellence sector
14 mai 2024 05h53 HE
|
ALLIANCE PROMOTION MICROBIOTE
The Alliance Promotion Microbiote is becoming the European Microbiome Innovation for Health: a major step towards structuring the European microbiome excellence sector Paris - France - May 14, 2024 -...
World $2.5 Bn Human Microbiome Market Trends, Forecasts and Competitive Analysis 2018-2023 and 2024-2030
08 mai 2024 09h40 HE
|
Research and Markets
Dublin, May 08, 2024 (GLOBE NEWSWIRE) -- The "Human Microbiome Market: Trends, Forecast and Competitive Analysis [2024-2030]" report has been added to ResearchAndMarkets.com's offering.The global...
Microbiome Collaboration, R&D, and Licensing Deals Analysis Report 2024 with Directory of 243 Agreements Signed Since 2016
07 mai 2024 07h35 HE
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Microbiome Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Microbiome Collaboration and...
Global Microbiome Manufacturing Industry Research 2024: A $187 Billion Market by 2035 with Close to 170 Trials Evaluating Microbiome Therapeutics to Treat Infectious Diseases and Oncological Disorders
05 avr. 2024 04h51 HE
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Microbiome Manufacturing Market (3rd Edition): Industry Trends and Global Forecasts, till 2035: Distribution by Type of Product Manufactured, Type of...
EnteroBiotix Completes £27m Financing Round to Advance Clinical Trials
04 avr. 2024 03h00 HE
|
EnteroBiotix
GLASGOW, United Kingdom, April 04, 2024 (GLOBE NEWSWIRE) -- EnteroBiotix Limited, a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome therapeutics,...
EnteroBiotix Initiates Phase 2 Study of EBX-102-02 in Patients with Irritable Bowel Syndrome (IBS)
03 avr. 2024 03h00 HE
|
EnteroBiotix
GLASGOW, Scotland, April 03, 2024 (GLOBE NEWSWIRE) -- EnteroBiotix Limited, a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome therapeutics, today...